Clinical Trial Update: PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PMZ-1620 (Sovateltide) in patients with acute spinal cord injury is currently recruiting. No results are reported at this time…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Sovateltide (sovateltide)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Acute Spinal Cord Injury | Phase 2 | Status: RECRUITING